Qualtec (9165) FY2026 Q2 Earnings Report

Quick View

Executive Summary

Cumulative results for 2026 Fiscal Year Q2 showed significant increases in Operating Income, Ordinary Income, and Net Income, driven by revenue growth and an improvement in the gross margin resulting from the containment of the cost of sales. Revenue increased 6.8% year on year to ¥20.6B, Operating Income increased 33.8% to ¥2.1B, Ordinary Income increased 34.3% to ¥2.1B, and Net Income increased 45.6% to ¥1.4B. The primary reason that the earnings growth rates substantially exceeded the revenue growth rate was the improvement in the gross margin, as the cost of sales increased by only 0.5%, indicating earnings growth accompanied by improved profitability quality.

Factors Affecting Performance

【Revenue】Revenue was ¥20.6B, an increase of 6.8% year on year. Demand in the existing businesses, centered on the Reliability Evaluation Business and Fine Processing Business, appears to have remained solid.

【Profit and Loss】The cost of sales increased by only 0.5% year on year, substantially below revenue growth, resulting in a 410bp improvement in the gross margin from 29.7% to 33.8%. SG&A expenses increased 17.1% to ¥4.9B, exceeding the revenue growth rate; however, the 21.6% increase in gross profit absorbed this increase, and the Operating Income margin rose 210bp from 8.1% to 10.2%. Ordinary Income was ¥2.1B, approximately the same level as Operating Income, as non-operating income and expenses were broadly balanced. Profit Before Tax was slightly below Operating Income due to extraordinary losses of ¥0.1B, including an impairment loss of ¥0.1B; however, Net Income increased 45.6% to ¥1.4B, partly due to a lower income tax burden. Overall, the results showed both revenue and earnings growth, with the earnings growth rate exceeding the revenue growth rate, representing a high-quality earnings performance.

Segment Analysis

Although specific numerical disclosures regarding segment operating profit or loss are not available, the Reliability Evaluation Business and Fine Processing Business are reported segments, while Bio, Zero, and Innovation businesses are classified under “Other.” Within the “Other” category, an impairment loss of ¥0.1B was recorded in the Bio-related business, suggesting that asset profitability in this area is relatively low.

Key Financial Indicators

【Profitability】The Operating Income margin of 10.2% improved by 210bp from 8.1% in the same period of the previous year, while the Net Income margin also increased from 4.8% to 6.6%. The improvement in the gross margin to 33.8% from 29.7% in the previous year drove the overall improvement.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥4.2B, approximately 3.1 times Net Income of ¥1.4B, indicating favorable cash conversion. Depreciation and amortization of ¥2.2B and a ¥0.4B decrease in trade receivables contributed to OCF, while inventories were a ¥0.9B source of cash outflow.【Investment Efficiency】Annualized ROE was 8.1%, primarily due to the improvement in the Net Income margin, while the asset-intensive asset structure leaves room for improvement in total asset turnover. Capital expenditures of ¥2.6B exceeded depreciation and amortization of ¥2.2B, indicating that the company remains in a phase of investment exceeding depreciation.【Financial Soundness】With an Equity Ratio of 74.1% and cash and deposits of ¥15.7B, the financial foundation is conservative. Interest-bearing debt consists only of ¥1.2B in short-term borrowings, limiting interest expense and repayment risk.

Cash Flow Analysis

Operating Cash Flow was ¥4.2B, a substantial increase of +209.5% year on year, demonstrating cash generation capacity well in excess of Net Income of ¥1.4B. The key drivers of the increase were depreciation and amortization of ¥2.2B and a ¥0.4B decrease in trade receivables, while a ¥0.9B increase in inventories was a source of cash outflow. Investing Cash Flow was negative ¥2.6B, primarily due to capital expenditures of ¥2.6B; however, this was sufficiently covered by OCF, resulting in positive Free Cash Flow of ¥1.6B. Financing Cash Flow was negative ¥1.3B, mainly reflecting dividend payments of ¥0.9B and other items. Overall, the company’s cash generation structure allows investment and shareholder returns to be funded through internal resources.

Earnings Quality

The difference between Ordinary Income and Net Income was primarily attributable to extraordinary losses of ¥0.1B, comprising an impairment loss of ¥0.1B, losses on disposal of fixed assets, and other items; consequently, Profit Before Tax was slightly below Operating Income. Non-operating income and expenses were both minor, and Ordinary Income can be considered to broadly reflect the underlying strength of the core business. The fact that OCF reached approximately 3.1 times Net Income indicates that earnings do not depend on non-cash factors such as an increase in trade receivables, supporting an assessment of high earnings quality. Meanwhile, the increase in inventories, primarily work in progress, indicates a cash tie-up in working capital and could become a source of future cash flow volatility depending on project progress and the timing of acceptance inspections.

Earnings Forecast and Guidance

Progress against the full-year company forecasts was 46.8% for Revenue, 51.6% for Operating Income, 51.5% for Ordinary Income, and 49.8% for Net Income. First-half results have generally tracked around the standard progress rate of approximately 50%. However, the Operating Income margin assumed in the full-year forecast is 9.2% (forecast Operating Income of ¥4.0B ÷ forecast Revenue of ¥44.0B), below the first-half actual result of 10.2%. This suggests that the company plans for a modest decline in the profit margin in the second half compared with the first half, due to factors such as higher SG&A expenses and changes in the project mix. No revision has been made to the dividend forecast.

Shareholder Returns

The Q2 dividend was ¥0 per share, while the full-year company forecast is a dividend of ¥37 per share. The Payout Ratio against forecast full-year EPS of ¥115.43 is approximately 32.1%, below the generally cited sustainability benchmark of 60%. First-half OCF of ¥4.2B and Free Cash Flow of ¥1.6B sufficiently cover the expected annual total dividend amount of approximately ¥0.9B, based on 2.35 million shares outstanding, providing financial support for continued dividend payments. No disclosure regarding share repurchases has been made.

Risk Factors

1. Inventory accumulation risk, particularly work in progress: The majority of inventories consists of work in progress of ¥1.97B, which increased by ¥0.9B during the first half. Delays in project progress or postponements in acceptance inspections could lead to delays in revenue recognition and deterioration in OCF.

2. SG&A expense growth and profit margin volatility risk: SG&A expenses increased 17.1% year on year, exceeding the 6.8% revenue growth rate. The full-year plan assumes an Operating Income margin of 9.2%, below the first-half actual result; if the improvement in the gross margin slows in the second half, profit margins could come under pressure.

3. Impairment risk for individual assets: An impairment loss of ¥0.06B was recorded in the Bio-related business. If progress toward commercialization in new or peripheral business areas falls below plan, additional asset impairments could occur.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (it_telecom)

Profitability and Returns

Profitability is below the industry median, placing the company in the middle to lower range within the industry.

Growth and Capital Efficiency

The revenue growth rate is substantially below the industry median, indicating that the pace of top-line expansion is relatively moderate within the industry.

Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. The Operating Income margin improved by 210bp year on year to 10.2%, confirming high-quality earnings growth accompanied by an improved gross margin. However, compared with the industry median, both profitability and growth are below average, positioning the company in the middle or lower range within the industry.

2. OCF was approximately 3.1 times Net Income, and Free Cash Flow was positive at ¥1.6B, indicating favorable cash conversion. Together with the Equity Ratio of 74.1% and low interest-bearing debt, the company’s financial foundation is conservative.

3. The full-year plan incorporates a decline in the second-half Operating Income margin to approximately 8.4%. Whether this decline is attributable to temporary factors or reflects a structural increase in the SG&A burden will be a key point to monitor in future earnings results.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,292–¥1,366 at ±1% for the cost of equity, and ¥1,326–¥1,330 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used; there is a timing difference relative to the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.

---End of Report---